VentriPoint Diagnostics Ltd.
VPT - TSX Venture
Shares issued: - 79.4 million
Fully diluted: - 99.6 million
*****************************
Today, VentriPoint announced that Dr. John Kovalchin will lead the clinical trials to validate VMS™ for Tetralogy of Fallot or blue-baby syndrome. John P. Kovalchin, MD, is Director of Echocardiography at The Heart Center at Nationwide Children's Hospital. Associate Professor of Pediatrics at The Ohio State University College of Medicine.
The collaborative trials will include five hospitals - Omaha Children’s in Nebraska; Nationwide in Columbus, Ohio; The Cleveland Clinic and two others.
According to the news release, data from the trial will underpin a submission to the FDA, which is slated for the end of this year.
About Nationwide Children's Hospital
Ranked in the top 12 on U.S. News & World Report's 2007 list of "America's Best Children's Hospitals," Nationwide Children's Hospital is one of the nation's largest pediatric healthcare networks. As home to the Department of Pediatrics of The Ohio State University College of Medicine, Nationwide Children's Hospital physicians train the next generation of pediatricians and pediatric specialists. The Heart Center at Nationwide Children's Hospital is one of five comprehensive centers in the nation dedicated to pediatric cardiac care, education and research. The Heart Center features the latest surgical equipment and diagnostic technology available, including the world's first Hybrid Cardiac Catheterization Suites and the nation's first Congenital Cardiac Hybrid Operating Suite.
Please click here, to view the full news release
0 comments:
Post a Comment